Northpond Ventures, LP - Jun 4, 2025 SCHEDULE 13G Report for Mereo BioPharma Group plc Ordinary Shares, par value GBP 0.003 per share (MREO)

Filing Manager
Northpond Ventures, LP
Reporting Manager
Michael P. Rubin
Security
Mereo BioPharma Group plc Ordinary Shares, par value GBP 0.003 per share
Symbol
MREO
Shares outstanding
790M shares
Disclosed Ownership
54.5M shares
Ownership
6.9%
Form type
SCHEDULE 13G
Date filed
6/11/2025, 07:51 PM
Date of event
Jun 4, 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Northpond Ventures, LP 4.4% 35.2M 0 35.2M /s/ Patrick Smerkers By: Northpond Ventures GP, LLC, its General Partner, By Patrick Smerkers, Authorized Signatory
Northpond Ventures GP, LLC 4.4% 35.2M 0 35.2M /s/ Patrick Smerkers By Patrick Smerkers, Authorized Signatory
Northpond Ventures II, LP 2.1% 16.5M 0 16.5M /s/ Patrick Smerkers By: Northpond Ventures II GP, LLC, its General Partner, By Patrick Smerkers, Authorized Signatory
Northpond Ventures II GP, LLC 2.1% 16.5M 0 16.5M /s/ Patrick Smerkers By Patrick Smerkers, Authorized Signatory
NPV Listed, LLC 0.4% 2.84M 0 2.84M /s/ Patrick Smerkers By Northpond Ventures, LLC, its Manager, By Patrick Smerkers, CFO, Partner
Northpond Ventures, LLC 0.4% 2.84M 0 2.84M /s/ Patrick Smerkers By Patrick Smerkers, CFO, Partner
Michael P. Rubin 6.9% 54.5M 0 54.5M /s/ Michael P. Rubin Michael P. Rubin